Software license from cresset biomolecular discovery LTD:1262990 [19-001962]
Ended Purchase Order Awarded Last action
- Contract number
- 75N95019P00194
- Awardee
-
Cresset Biomolecular Discovery LIMITED UEI YFVNHK9FS147
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $82,824
Award facts
- Opportunity
-
- Chemical modeling software license Pre-Solicitation · 75N95019Q00072 · Posted Jan 29, 2019
- Chemical modeling software license Solicitation · Posted Feb 15, 2019
- Contract value 100% obligated
- $82,823.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541519 Other Computer Related Services
- PSC
- 7030 Information Technology Software
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Great Britain, United Kingdom
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $28,300 | |
| Exercise an Option | $27,600 | |
| Original award | $26,924 |
About this award
This is a $82,823.54 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the National Institutes of Health (NIH), to Cresset Biomolecular Discovery LIMITED, a for-profit organization based in the United Kingdom. The contract is for a software license for 5 users to aid NCATS' chemists with 3D structure-activity relationship (SAR) analysis, generation of novel and diverse molecular structures using bioisosteres, and understanding SAR and design. The contract has a base period of performance from March 1, 2019 to February 29, 2020, with two 1-year option periods. There was no set-aside used for this award.
Quick answers
Who was awarded contract 75N95019P00194?
75N95019P00194 was awarded to Cresset Biomolecular Discovery LIMITED by National Institute on Drug Abuse (National Institutes of Health) on February 28, 2019.
How much is contract 75N95019P00194 worth?
The government has obligated $82,824 on 75N95019P00194.
Which agency awarded contract 75N95019P00194?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019P00194, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95019P00194 competed?
The extent of competition for 75N95019P00194 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award